[ad_1] La rancune apparente sur le processus d’achat de médicaments a incité AbbVie (ABBV + 3,4%) de poursuivre en justice le National Health Service (NHS) d’Angleterre pour son intention de débarrasser le …
Read More »
[ad_1] Photographie par rawpixel Taille du texte AbbVie (ticker: ABBV), Rockwell Automation (ROK) et Estee Lauder (EL) ont tous annoncé des hausses de dividendes cette semaine. La plus importante …
Read More »
[ad_1] AbbVie Shares Inc. ABBV, -0.81% rose 3% before market on Friday, after the drug company exceeded its estimates for the third quarter, raised its forecasts and increased its dividend. The company …
Read More »
[ad_1] It was a tumultuous fall for AbbVie. In the weeks leading up to the pharmaceutical company's third quarter earnings report, on Nov. 2, the group resolved a series of patent litigation …
Read More »
[ad_1] AbbVie beats and student Major biotech company AbbVie (ABBV) reported a record pre-market performance in the third quarter on Friday. These are the main points of his press release: Reports diluted …
Read More »[ad_1] Written by Alia Paavola | September 19, 2018 | <a href = "http://www.beckershospitalreview.com/pharmacy/abbvie-hit-with-lawsuit-over-alleged-1-2b-dollar-kickback-scheme.html?tmpl=component&print=1" Data Tracking = "print" title = "Print the article < AbbVie hit with lawsuit over alleged $1.2B kickback …
Read More »
[ad_1] JB Reed | Bloomberg | Getty Images Humira, the treatment for injectable rheumatoid arthritis is photographed in a pharmacy in Cambridge, Massachusetts. The AbbVie shares fell nearly 3% on Tuesday after …
Read More »